Abstract
Introduction

36
Room temperature protein preservation is important for food, biologics, purified protein products (e.g. electrospun into a fiber matrix that, when a biofluid sample is added, simultaneously absorbs the sample as it 76 dissolves and mixes with it. We designed this method to reach a spatially uniform concentration of 77 lyoprotectants in the sample without requiring mixing, which it detrimental to proteins. Overnight drying of 78 the sample-lyoprotectant mix results in a hard, glassy sample that can be stored at room temperature(2).
79
In our work to preserve clinical serum samples by isothermal vitrification, dextran is essential since it 80 gives the dried samples the high glass transition temperature needed to maintain stability at room temperature.
81
However, conjugation of biomarker proteins with lyoprotectants like dextran could be very detrimental to 82 downstream proteinaceous biomarkers analysis, especially when analytical techniques that are based on specific 83 binding (such as ELISA) are to be utilized to detect activity. In this work, we analyzed the damage to vitrified 84 human serum proteins caused by conjugation with dextran during dried state storage, and we found that 85 replacing dextran in our lyoprotectant formulation with a reduced dextran (dextranol) (Fig 1) 
165
A 2-10 mg piece of vitrified serum in either dextran-based or dextranol-matrix was analyzed by ramping the 166 temperature to 150°C at a rate of 10°C/minute after equilibrating at -60°C. Data was collected every second.
167
We analyzed the data using a custom python script that identified the T g (glass transition) as the maximum 
172
Gel electrophoresis and staining 173 We carried out gel electrophoresis using Invitrogen NuPAGE and NativePAGE system (ThermoFisher 174 Scientific, Waltham, MA). For serum analysis, we loaded the equivalent of 0.4 L of serum (i.e. 4 L of diluted 175 serum) per well in a 10 well gel. We prepared samples either with NativePAGE buffer for native gel 176 electrophoresis or with LDS sample buffer and the reducing agent for denatured samples, and with LDS sample 177 buffer and the reducing agent for denatured and reduced samples. We boiled both the denatured as well as the 178 denatured and reduced samples for 10 minutes prior to loading on the gel. We ran the gels for 75 minutes at a 179 potential of 150 V. 
Results
203
We found that when we used dextran-based lyoprotectant matrix to preserve blood serum by isothermal 204 vitrification, serum began to show signs of damage over time. The damage was detected by the appearance of 205 high-molecular weight smearing seen in gel electrophoresis. While freshly vitrified (and immediately 206 reconstituted) serum appears identical to fresh or frozen serum on gel electrophoresis, after sixteen weeks the 207 smearing becomes very prominent (Fig 2) , especially when the samples are stored at elevated temperatures.
208
Individual protein bands are less detectable due to decreased intensity and smearing. While smearing is possibly 209 worse in native protein gels (Fig 2A), denatured (Fig 2B) , and denatured & reduced (Fig 2C) 
225
High molecular weight smearing and glycosylation increased both with storage time and storage 226 temperature and were accompanied by increased solubility. Smearing was faint after only 1 month of storage at 227 room temperature, but increased when either storage temperature was increased to 37°C or storage time was 228 extended to six months (Fig 3A) . These effects were additive as after six months of storage at elevated 229 temperature the smearing and decrease in individual protein band contrasts was significantly worse than storage 230 either for six months at room temperature or for one month at elevated temperature. Concurrent with the 232 indicates that high-molecular weight bodies in the smear are becoming significantly glycosylated. We also 233 noticed that samples that had become more soluble and would not precipitate efficiently using a standard TCA 234 precipitation protocol (S1 Fig, S1 Table) . (Figs 4 and S4) . Samples that were frozen, freshly vitrified in dextran-based matrix or dextranol-247 based matrix were all virtually indistinguishable from fresh, never frozen serum when analyzed by gel 248 electrophoresis under either native (Fig 4A) or denaturing conditions (Fig 4C) . However, after 140 days of 249 storage at 37°C, vitrified samples in dextran-based matrix showed significant smearing, while dextranol-based 250 matrix samples were almost indistinguishable from frozen or fresh serum. 
235
260
The glass transition temperature of the vitrified serum in either dextran or dextranol-based matrix was 50-55°C 261 ( S3 Fig). Therefore, in all storage experiments, the storage temperatures were kept below 50°C. Storage at 262 higher temperatures allowed us to simulate longer duration storage at room temperature. While decay reactions 263 do not uniformly scale with temperature, we expect a doubling in decay rates every 5-10°C increase (47). Thus 264 37°C storage corresponded to two to eight times faster aging while 45°C storage corresponded to four to twenty 265 times faster aging. BSA vitrified and stored in dextran-based matrix immediately after drying looked identical 266 to a frozen control, but after storage for 1-2 weeks at 45°C, the band from the main BSA monomer was highly 267 diminished, largely replaced by a high-molecular weight smear (Fig 5A) . Dextranol-based matrix was able to 268 effectively eliminate this damage, with the sample stored at 45°C for two weeks looking indistinguishable from 269 the freshly vitrified sample and very similar to the frozen aliquot. 278 In addition to protecting BSA, the dextranol-based matrix also protected human serum proteins when 280 isothermally vitrified and stored at higher temperature. Most protein bands became largely diminished when 281 the sample was stored for one or two weeks in a dextran-based matrix (Fig 5B) , and were replaced by a high-282 molecular weight smear, but storage in dextranol-based matrix protected the proteins. The serum proteins look 283 indistinguishable from freshly vitrified serum after 2 weeks at 45°C, and looked very similar to frozen serum.
284
In addition to providing overall protection to high abundance serum proteins, and albumin specifically, 285 we also found that dextranol-based lyoprotectant matrix provided much better protection than the dextran-286 based matrix for four individual proteinaceous biomarkers in the high-temperature stored serum samples. We 287 selected 4 cancer biomarkers to be tested for stability. All four biomarkers that were examined (prostate specific 288 antigen, neuropilin-1, osteopontin, and metalloproteinase 7) showed losses (as measured by ELISA) after one 289 or two weeks of storage at 45°C (Fig 6 and S2 Table) . In dextranol-based matrix, PSA (Fig 6A) and neuropilin 290 (Fig 6B) levels on day 1 were slightly reduced, potentially due to the drying process (by 7 and 8%, respectively), 291 but were stable during seven or fourteen days of storage. MMP-7 levels (Fig 6D) in dextranol-based matrices 292 remained slightly above the frozen control throughout this experiment. However, osteopontin levels in the 293 dextranol-based matrices fell in a similar pattern to that seen in dextran-based fibers, although not quite to the 294 same extent. 
315
Despite the knowledge of the conjugation potential of dextran in food science, researchers in the 316 pharmaceutics filed, in spite of observing protein damage in the presence of dextran, did not identify the 317 mechanism of the damage. Lyophilization research that focused on therapeutic proteins established that 318 formulations containing dextrans cause increase in protein size, increases solubility, and altered acidity, but this 319 was interpreted as aggregation or damage, and not attributed to dextran-protein conjugation. Studies using size 320 exclusion chromatography observe increased protein size after storage with dextran and speculate that this is 321 caused by "soluble aggregation" (50-56). However, size exclusion chromatography cannot distinguish dextran 322 conjugated proteins from dimeric or oligomeric protein "aggregates". Thus, the "soluble aggregates" reported 323 may instead be dextran conjugates (potentially, in addition to protein self-aggregation). Similarly, studies that 324 used dextran as a lyoprotectant that reported increased solubility (57) and acidity (58) 
